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Post-traumatic Stress Disorder (PTSD) is a debilitating psychiatric disease that 
often follows acute or chronic exposure to extreme stress. Hallmarks of this disorder 
include stressors, intrusion symptoms, avoidance, negative alterations in cognition and 
mood, and alterations in arousal and reactivity (Bovin, 2015). Since it was first defined in 
the Diagnostic and Statistical Manual of Mental Disorders-III (DSM-III), the diagnostic 
criteria for PTSD have evolved to encompass stressors as they may occur repeatedly 
across the lifespan (Bovin, 2015). Physiological and behavioral consequences of this 
extreme stress manifest themselves as systemic alterations in form and function. As is 
true of many diagnosable conditions, PTSD is most prevalent in African Americans and 
an estimated one in 11 people will be diagnosed in their lifetime (Torres, 2020). More 
recent studies have elucidated that race-based traumatic stress elicits a chronic stress 
response that mimics that of PTSD (Carter, 2020). While this disorder causes primary 
changes to the brain, further downstream effects cause global corporal alterations and 
lead to maladaptive responses to future stressors. 
Previous studies have demonstrated that the hippocampus, amygdala, and medial 
prefrontal cortex play important roles in PTSD. Studies have expanded on these findings 
and traced their effects downstream in other body systems including the immune system, 
central nervous system, digestive system, and endocrine system (Stam, 2007). Though 
there is a significant understanding of the psychological and physiological manifestations 
of PTSD, the interactions of the distal branching effects of this disorder on the body are 
less substantiated as they relate to racial trauma. Only more recently have researchers 




This capstone project is a literature review of the chronic stress response, secondary and 
downstream effects of stress on the numerous body systems, and their integrated 
implications on health as they relate to race-based stress. The research collected explores 
the physiological and neurobehavioral alterations which take place secondary to general 
trauma exposure, the long-term consequences of chronic stress, and the role of race as a 
social determinant of health. Various medical and academic interventions will be 








Allostasis and the Individual Stress Response 
Stress has many working definitions but is concisely defined as an emotional or 
physical stimulus that disrupts homeostasis and may result in pathology (Stam, 2007). 
This response is non-specific as it does not affect one particular system, but many parts of 
the global system due to their inherent connections. Levine and Ursin (2013) defined 
stress as a condition caused by a lack of information leading to uncertainty or 
unpredictability about obtaining positive outcomes or avoiding negative outcomes. Such 
stress may follow a potential threat to the vital interests of the organism in which 
physiological and behavioral mechanisms are activated to eliminate the source of the 
stress and restore homeostasis (Levine and Ursin, 2013). Stress is a normal and essential 
physiological response, but when these responses become unregulated or occur in excess, 
problems arise.  
Systemic changes occur following exposure to stressors. Much like the immune 
system, the body as a whole changes following exposure to specific and controllable 
stressors. These stressors prime the system for more refined and efficient responses 
during a second encounter. The subsequent changes are less adaptive when the source of 
stress is not immediately controllable (Stam, 2007). As stated by Stam (2007), when the 
source of stress is not acutely constrained, the stress response triggers a reorganization of 
neuronal circuitry in the brain and an acquisition of novel strategies to address the threat. 
If the stress response is repeated or sustained for an extended period without removal of 
the stressor, or if the stressful experience is so overwhelming that it over-taxes the 




Allostasis is defined as achieving stability through change, or the process by 
which the organism maintains homeostasis in the face of new challenges (Faber, 2020). 
Allostatic systems enable an organism to maintain its essential functions in balance 
(McEwen, 2017). To maintain an allostatic state, the brain overrides the local effects of 
homeostasis in individual organs to allow for optimal global functioning. Allostasis is 
ultimately beneficial in that it allows for adaptation over time. This adaptation is achieved 
via ongoing evaluation of internal and external demands which permit physiological 
adjustments in advance of stress via anticipatory arousal (Ganzel, 2010).  
Per McEwen (2017), the body initiates an allostatic response under normal 
circumstances to cope with a stressor for the duration of its presence. Once the challenge 
has passed, the body turns this response off. Two primary mediators of this ever-adapting 
system are the sympathetic nervous system and the Hypothalamic-Pituitary-Adrenal 
(HPA) axis. The activation of these systems leads to the release of catecholamines and 
other accompanying hormones, such as cortisol, while the deactivation results in a 
regression to baseline hormonal concentrations. When the allostatic response is limited to 
the period of challenge, adaptive protection outweighs adverse consequences. However, 
with persistent stress over weeks, months, or even years, the body is exposed to elevated 
levels of stress hormones and allostatic overload, resulting in pathophysiological damage 
(McEwen, 2017). McEwen went on to define allostatic load as the physiological cost 
associated with long-term, global changes across the body systems to match internal 
functioning to external demand. With persistent stress, the body’s delicate and 




dysregulation and leave these regulatory mechanisms catastrophically out of alignment 
(McEwen, 2017). 
Under normal physiological conditions, the system’s response to stress is highly 
individualized but ultimately occurs within stable and predictable limits defined by 
homeostasis. The individuality of the stress response depends on an individual’s appraisal 
process, coping style, and social milieu. Individuals will experience a variable stress 
response based upon their experience of uncertainty and their subsequent appraisal of 
their ability to restore homeostasis. The appraisal process may be influenced by a 
person’s social environment, race, ethnicity, biological sex, gender identity, 
socioeconomic status, and various other intersecting social determinants of health. In an 
example offered by Stam (2007), PTSD is more prevalent in biological females not 
necessarily due to increased exposure to traumatic events, but likely due to differences in 
coping styles, socio-economic resources, and levels of autonomic and hormonal arousal. 
Stam (2007) went on to explain that the psychological factors involved in gender-based 
differences in PTSD occurrence also play a role in gender-independent differences in 
PTSD vulnerability (Stam, 2007). 
Part of this stress response process depends on a person’s locus of control. In a 
study conducted by Karstoft (2015), locus of control and coping style were found to be 
highly predictive of PTSD outcomes. Specifically, an internal locus of control was 
correlated with a decreased risk of PTSD symptoms, as was the employment of problem-
focused coping strategies as opposed to emotion-focused coping (Karstoft, 2015). 
Inability to cope with stress may result in clinically significant consequences in 




Mental Disorders-5 (DSM-5), higher rates of PTSD have been reported among U.S. 
Latinx, African Americans, and American Indians compared to other ethnic 
demographics (Trauma- and stressor-related disorders, 2013). 
The stress response is made increasingly discrete and unpredictable by the 
involvement of epigenetic factors, particularly those involved in the pathogenesis of 
PTSD. Dr. Madhulika Gupta, M.D. (2013) stated environmental factors such as early life 
stress can modify gene expression via DNA methylation and histone modification. DNA 
methylation has been found to reduce gene expression while early life stressors have been 
implicated in the increased methylation of glucocorticoid receptor expression. The 
glucocorticoid receptor plays a critical role in the negative feedback regulation of the 
HPA axis. On a systemic level, these epigenetic mechanisms have been associated with 
the mechanisms of fear learning and memory consolidation which play a central role in 















Post-traumatic stress disorder (PTSD) 
 The American Psychiatric Association revised the diagnostic criteria of post-
traumatic stress disorder (PTSD) in its fifth edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5). Per this most recent definition, PTSD is defined 
as “the development of characteristic symptoms following exposure to one or more 
traumatic events.” These characteristic symptoms include intrusion symptoms, 
avoidance, negative alterations in cognition and mood, and alterations in arousal and 
reactivity. Intrusion symptoms include involuntary memories, recurrent and distressing 
dreams, and realistic flashbacks about the traumatic event. These intrusion symptoms are 
accompanied by avoidance of internal and external stimuli associated with the event. 
PTSD is distinguished from other trauma- and stressor-related disorders based on both 
timing and symptom profile (Trauma- and stressor-related disorders, 2013).  
 




Per the DSM-5, an appropriate PTSD diagnosis may specify whether the 
individual’s symptoms include intrusion symptoms such as depersonalization or 
derealization, or if these symptoms occurred with delayed expression. The functional 
consequences of this disorder include impaired functioning across social, interpersonal, 
developmental, educational, physical health, and occupational domains (Trauma- and 
stressor-related disorders, 2013). The manifestations of this disorder exist on a spectrum, 
but nearly ubiquitously affect diagnosed individuals daily. 
 
The Chronic Stress Response 
The hallmark psychological symptoms of PTSD are associated with various 
somatic symptoms and medical conditions affecting multiple body systems. Further, 
these primary physical effects of PTSD are accompanied by secondary alterations in 
experience and quality of life. With the experience of chronic stress and allostatic 
overload, an individual’s health is markedly affected. As hormones such as cortisol 
circulate in the body, fat is mobilized as sugar for use in the fight-or-flight response. 
Unused sugar is re-stored as fat in the midsection, potentially damaging the vital organs 
located in the region. The elevation of blood pressure and heart rate which accompany 
this sympathetic response can, in excess, lead to hypertension or cardiomegaly 
(Greenberg, 2020). Beyond the diagnosable symptoms of PTSD, chronic stress causes 
significant alterations across multiple mechanisms and profoundly exaggerates systemic 
damage.  
Following exposure to a traumatic event, individuals diagnosed with PTSD 
experience notable changes in neuroanatomy, as well as the CNS. Structural and 




the exacerbation of PTSD symptoms such as hypervigilance. Holmes (2018) identified 
structural and functional alterations in the prefrontal cortex (PFC), hippocampus, 
amygdala, and cerebellum. Structurally, individuals with PTSD presented with smaller 
cerebellar, hippocampal, and PFC volume. Functionally, connectivity in the cerebellum 
and PFC were negatively correlated with PTSD severity, while the amygdala 
demonstrated increased activity. Analyses in this study revealed weakened connectivity 
within nodes of the central executive network of the PFC, as well as between nodes of the 
default mode network in the PFC and cerebellum. These deficits in cerebellar 
connectivity manifested as symptoms such as intrusive thoughts and avoidance. These 
findings were consistent with well-established knowledge on PTSD pathophysiology and 
the growing support of the involvement of the cerebellum (Holmes, 2018). 
As has been established, patients diagnosed with PTSD develop neuroanatomic 
changes in the hippocampus, amygdala, and cortex. Reduced volume and activity in the 
amygdala alter stress responses and the extinction of memories. Increased activity in the 
amygdala promotes hypervigilance and impairs discrimination of threats. Reduced 
prefrontal cortical volume dysregulates executive function, reduced anterior cingulate 
volume impairs the extinction of fear responses, and decreased medial prefrontal 
activation leads to uncertain effects. These modifications cause neural circuitry to 
reorganize in a form of non-associative learning to strengthen defensive reflexes to 
previously neutral stimuli (Sherin, 2011). 
Per Bremner (2006), persons with PTSD show increased cortisol and 
norepinephrine responses to stress, consistent with the traumatic stress response. In the 




fear. As is summarized in the image below, corticotropin-releasing hormone (CRH), part 
of the HPA axis, is released from the hypothalamus in response to stress. This stimulates 
the release of adrenocorticotropic hormone (ACTH) from the pituitary and the 
subsequent release of cortisol from the adrenal gland. This eventually results in negative 
feedback on the HPA axis. While cortisol facilitates survival in instances of acute danger, 
it is accompanied by CRH which centrally mediates fear behaviors and triggers 
downstream neurochemical responses to stress. One of these downstream responses 
involves the noradrenergic system located in the locus coeruleus of the brain stem. This 
system is associated with increased alertness and hypervigilance. As this neural circuitry 
becomes reorganized over time, the brain’s defensive reflexes against previously neutral 
stimuli are maladaptively strengthened. This learned hyperresponsivity has lasting effects 
on the rest of the body (Bremner, 2006).  
 
 





Neurobiological features of PTSD occur with abnormalities and further functional 
implications. The proinflammatory cytokines and stress hormones of the HPA axis do not 
exist in a vacuum, but are systemically impactful. Neuroendocrine shifts such as 
hypocortisolism and increased CRH drive abnormal stress processing and promote 
hippocampal atrophy, respectively. Parallel imbalances in the T3:T4 thyroid hormone 
ratio increase subjective anxiety (Sherin, 2011).  
Variations in neurochemicals including catecholamines, serotonin, amino acids, 
and peptides each contribute to marked PTSD symptomatology. Increases in 
catecholamines such as dopamine and norepinephrine (NE) interfere with fear 
conditioning and increase arousal in the startle response. NE specifically increases pulse, 
blood pressure, and response to memories in individuals diagnosed with PTSD. 
Decreased serotonin levels in the many parts of the raphe nucleus disturb the dynamics 
between the amygdala and hippocampus, compromise anxiolytic effects, and increase 
vigilance. Decreases in amino acids such as GABA similarly increase anxiolytic effects, 
while increases in glutamate foster derealization and dissociation. Decreased plasma 
neuropeptide Y (NPY) leaves CRH and NE unopposed and upregulates the stress 
response. Increases in CSF β-endorphin levels foster numbing, stress-induced analgesia, 
and dissociation. These many changes stimulate the sympathetic nervous system (SNS) 
and trigger a potentially untimely fight-or-flight response. This hyperresponsivity of the 
CNS leads to altered processing of visceral and sensory stimuli (Sherin, 2011). 
On a broader scale, traumatic stress in PTSD often co-occurs with global changes 
in immune function. These systemic changes include altered glucocorticoid sensitivity in 




(Neigh, 2016). Neigh (2016) described multiple candidate mechanisms of immune 
dysfunction in PTSD. While the dogmatic understanding of PTSD associates the disorder 
with elevated cortisol and catecholamine concentrations in response to stress, excessive 
activation of the HPA axis in this pathophysiology results in reduced circulating cortisol 
levels. In response to a sustained increase in CRH and this excess activation, CRH 
receptors are downregulated. This results in a reduction of downstream cortisol secretion 
and increased glucocorticoid sensitivity. These changes are linked to increased cytokine 
production and the hyper-inflammatory state comorbid with PTSD (Neigh, 2016).  
The chronic low-grade inflammation consistent with PTSD is linked to numerous 
inflammatory biomarkers. The proinflammatory cytokines tumor necrosis factor α (TNF-
α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) have been implicated in the 
augmentation of PTSD symptoms in response to subsequent stressors. Cytokines 
additionally influence the HPA axis’ signaling capabilities and impair cellular processes 
by stimulating oxidative stress. Studies have associated reactive oxygen species and 






Figure 2. A psychoneuroimmunological model of PTSD. Adapted from Neigh, 2016.  
 
While PTSD has been heavily correlated with several physical ailments, 
associations of this disorder with cardiovascular disease (CVD) are of particular concern. 
The cardiovascular consequences of psychological trauma were described by Arenson 
(2017) as occurring in both immediate and delayed fashions. Of note, individuals with 
PTSD are twice as likely to die from CVD compared to control groups. In the described 
participant group, each incremental increase in PTSD symptoms corresponded to a 20% 
increase in the risk of heart disease mortality (Arenson, 2017). Buckley (2001) observed 
that compared to non-trauma-exposed individuals, individuals carrying a PTSD diagnosis 
have higher resting heart rates and elevated blood pressures. These positive associations 
between PTSD and basal cardiovascular activity were consistent with established 




hyperresponsivity, and the catecholamine dysregulation discussed previously, could put 
individuals with PTSD at risk for further pathological changes. 
In addition to CVD, PTSD has been established as a risk factor for both 
myocardial infarction (MI) and stroke (Remch, 2018). Remch (2008) went on to describe 
the negative role PTSD played in the individual healths of the study’s participant pool. 
Weight gain, tobacco and alcohol use, hypertension, and hyperlipidemia are all 
comorbidities of PTSD. Therefore, the negative effects of these afflictions are inseparable 
from a patients' general condition and, in particular, their increased risk of cardiac 
incident (Remch, 2008). 
At the intersection of the physical and emotional responses to stress is the gut. A 
system of bidirectional communication exists between the CNS and the digestive system 
called the gut-brain axis (GBA). Clapp (2017) expanded upon a growing field of research 
supporting the association of stress with gastrointestinal and extragastrointestinal 
diseases. Inversely, recent studies have also related dysbiosis and inflammation of the gut 
with mental illnesses such as anxiety and depression, which share prevalent 
symptomatology with PTSD. The resulting pathophysiology relating to this GBA 
dysfunction includes stress-induced mucosal immune alterations in intestinal 
permeability and impaired CNS ability to downregulate incoming visceral or somatic 





Figure 3. Gut-brain axis pathway diagram. Adapted from Clapp, 2017. 
 
In a study conducted by Gradus (2017), PTSD was associated with diagnosed 
upper and lower GI disorders, as well as irritable bowel syndrome (IBS), 
gastroesophageal reflux disorder, and dyspepsia. The risk of GI disorder among PTSD 
patients was observed at 25% with an overall incidence rate 1.8 times higher than that of 
the general population. While the observed risk of malignancy varied with each specific 
disorder, compelling evidence was found associating PTSD with peptic ulcers, 
esophagitis, cholelithiasis, gastritis, and duodenitis. Additionally, these authors found 
evidence of effect modification by psychiatric PTSD comorbidities including depression 




Unlike psychological comorbidities of trauma, which can develop in sequence or 
without a discernable pattern, physical post-traumatic symptomatology typically develops 
in parallel with the traumatic incident. Considerable physiological factors are common to 
both PTSD and chronic pain and are likely mutually reinforcing on a systemic level. The 
prevalence of PTSD is substantial in patients with chronic pain. Per Dr. Lorie 
DeCarvalho, Ph.D. (2019) of the U.S. Department of Veteran Affairs, 35% of current 
chronic pain patients also carry a diagnosis of PTSD compared to 3.5% of the general 
population. Inversely, the prevalence of chronic pain in individuals with PTSD is greater 
than in controls. Not only do individuals with PTSD experience higher rates of chronic 
pain, but this pain is quantified as increasingly intense when compared to control groups 
(DeCarvalho, 2019). 
In addition to the increased incidence of chronic pain in individuals with PTSD, 
this affected population experiences various alterations in pain perception. Compared to 
control groups, individuals with PTSD displayed hyposensitivity to pain accompanied by 
hyper-reactivity to suprathreshold noxious stimuli. These features are likely attributable 
to alterations in emotional interpretation and sensory processing of painful stimuli 
(Defrin, 2008). 
The inter-systemic effects of PTSD compound on one another and cause damage 
to the body over time. The compounding effects of these multiple pathologies accelerate 
the already grueling disease process of PTSD. These effects of chronic stress have 
secondary effects which place individuals at higher risk for comorbidities, alter their 
abilities to develop innate and adaptive immunity, shorten their telomeres, and place them 





Racism at the Cellular Level 
As stated by Kirkinis (2018), race as a social construct is well-established in the 
United States and has been used to categorize people into groups for centuries. This 
practice of grouping humans based on their eye shape, nose shape, hair texture, skin tone, 
etc. has resulted in racial groupings. These racial groupings exist in a social hierarchy 
that places Whites at the top and all people of color beneath that dominant group. As a 
result of this hierarchy, African Americans, Asians, Latinx, and Native Americans have 
and continue to endure systems of oppression as targets of variable forms of racism. 
Racism manifests as racial discrimination or the combination of ideological racial 
superiority with social structures associated with dominance and oppression. The 
subsequent normalization of these widespread inequities is called structural racism 
(Kirkinis, 2018). 
Increasing evidence exists demonstrating the connection between racial 
discrimination and a variety of negative physical and mental health outcomes. 
Continuous with the definition of stress as “the inability to meet the demands of a 
situation,” consequences exist for the experiential stress of racism or racism-related 
stress. When this race-based stress initiates a maladaptive psychological response, the 
resulting wounds to the self closely align with those observed in PTSD (Kirkinis, 2018). 
A growing body of research exists which explores the impact of racist and 
discriminatory encounters on physical health. Empirical evidence supporting the validity 
of these studies consistently mirrors that of studies conducted in the field of chronic 
stress. Harrell et al. (2003) established that external stressors associated with acts of 




to negative health outcomes. In this research, Harrell found that reactions to racism 
including anxiety and worry prompted rehearsed defensive reactions and aggressive 
responses as methods of coping and adaptation (Harrell, 2003). Examples of altered 
biological function in response to the physiological stress response include preterm or 
low birth weight deliveries, increased incidence of heart disease, and hypertension 





To ensure a high-quality review of literature, a comprehensive search was 
performed of peer-reviewed journals obtained from reputable databases. These databases 
included Google Scholar, NCBI, and PubMed Central. Further resources were obtained 
from the reference sections of each respective citation. All data and information 
discussed in this review were obtained by reading and reviewing this literature. Searches 














Racial Disparities in Medicine 
Independent of race’s biological significance on an individual level, the societal 
and social consequences of racism are substantial and indisputable. Due to the continued 
dependence on race as a social stratifier in the United States, the resulting racial hierarchy 
has contributed to marked inequalities in power, opportunity, resources, and social status 
(Dominguez, 2008). These inequalities are experienced by individuals of affected 
populations at a molecular level. The weathering effects of living in a race-conscious 
society are greatest among people of color, especially African Americans (Geronimus, 
2006). Research conducted in the realm of discrimination and racism suggests that the 
effects experienced by targeted individuals are consistent with those described in 
traumatic stress research (Carter, 2007). Pioneer to this field of study, Clark (1999) and 
Slavin (1991) asserted the perception of racism and racial hostility initiates stress 
reactions. The secondary and long-term effects of racial trauma manifest as systemic 
dysfunctions such as IBS and coronary artery disease (CAD), deterioration of birth 
outcomes, and emotional injury. 
Studies cited by Carter (2007) suggest that acute exposure to racism is associated 
with increased cardiovascular activation (CVR), while past exposure to racism impacts 
current CVR in reaction to race-related stressors. This finding supports the increased 
prevalence of self-reported stress and physiological response following repeated or 
sequential racial encounters in people of color (Carter, 2007). In addition to this increased 
incidence of CAD, race has been identified as a precipitating factor in the lifetime 




prevalent in African Americans than any other racial group and is known to increase the 
risk for CAD and stroke (American Heart Association, 2015). These cyclic comorbidities 
mimic those associated with cardiac dysfunctions in PTSD pathology. 
The association between IBS and PTSD has been previously established in non-
minority populations. Iorio (2014) investigated the same association in African American 
individuals, uncovering a significant relationship. This study produced results supporting 
an association between IBS and PTSD in people of color. African American individuals 
with IBS were twice as likely to suffer from PTSD, but this relationship is neither 
directional nor causal. Iorio went on to state that while the participants of this study 
carried histories of IBS before their subsequent PTSD diagnoses, it is impossible to 
determine which dysfunction preceded the other. IBS symptoms in this study’s 
participants were often accompanied by bodily pain, inhibition of social functioning, and 
mental health deficits. Each of these additional symptoms negatively correlates to PTSD 
severity (Iorio, 2014). 
The preceding physiological responses to racism and discrimination are 
moderated by variables of personality and cultural orientation (Harrell, 2003). Racism 
harms both physical and mental health. This impact, however, is not reflected in the 
theories of current psychological or psychiatric assessment models. Similar to the 
variability of the individual stress response, which depends upon appraisal and coping, 
researchers have asserted that stress outcomes relating to racial trauma vary based on 
racial group identity, frequency of discrimination, and severity of the traumatic event(s). 
The occurrence of such race-based incidents is positively associated with lower levels of 




observations in mind, emotional injury resulting from racial trauma should be assessed as 
a psychological symptom of racism with equal diagnostic significance to physical and 
mental health exam findings.    
Race-based Medicine 
Despite the failure of racially targeted drugs such as BiDil, a heart medication 
marketed toward African Americans, no clear guidelines exist on the use of race in 
medicine. Although sizable evidence exists disputing this notion, the belief that race is a 
reliable proxy for genetic difference has become insidiously embedded in medicine 
(Vyas, 2020). Subtle examples of this insidious insertion of race in medicine are observed 
in diagnostic algorithms and practice guidelines that adjust their outputs based on a 
patient’s racial or ethnic identification. These algorithms are employed to guide clinical 
decision-making but, due to their consideration of race, actively perpetuate race-based 
health inequities. A significant danger of these race-adjusted algorithms is the potential 
swaying of clinical decision-making in favor of white patients (Vyas, 2020). 
As stated by Vyas (2020), The American Heart Association’s Get with the 
Guidelines - Heart Failure Risk Score predicts the risk of mortality in patients with acute 
heart failure. This race-corrected stratification tool creates inequities by raising the 
threshold for using clinical resources for black patients. By awarding three points to the 
risk scores of non-black patients, black patients are thereby regarded as lower risk. 
Similarly, equations used by cardiac surgeons to determine the risk of operative mortality 
and major complications quantify black patients as having up to 20% greater risk than 
white patients. When used preoperatively, this calculation may steer black patients away 




Similar race-considering algorithms and practices exist throughout medicine, 
namely in Urology, Pulmonology, Endocrinology, Oncology, Nephrology, and 
Obstetrics. In the case of obstetrics, the Vaginal Birth after Cesarean (VBAC) algorithm 
is used to estimate the probability of successful vaginal birth following a prior cesarean 
section and further counsel patients on their medical decisions. This algorithm accounts 
for race by subtracting from the projected success rate in patients identifying as black or 
Hispanic. The lower estimates of success produced from this algorithm may dissuade 
clinicians from recommending vaginal deliveries to people of color and have concretely 
resulted in higher rates of cesarean section in non-white women (Vyas, 2020). This 
dynamic actively exacerbates preexisting racial disparities in obstetrics and gynecology, 
including heightened maternal mortality and morbidity rates in black mothers (Vyas, 
2019). 
Further investigating the concept of obstetric racism, the Centers for Disease 
Control and Prevention (CDC) conducts national pregnancy-related mortality and 
morbidity surveillance to better understand the present differential reproductive outcomes 
in the United States. The Pregnancy Mortality Surveillance System (PMSS) defines a 
pregnancy-related death as one occurring while a woman is pregnant (or within 1 year of 
pregnancy) which is aggravated or otherwise caused by the pregnancy. Since the 
implementation of this surveillance, trends in pregnancy-related mortality ratios have 
revealed considerable disparities based on race and ethnicity (Centers for Disease Control 
and Prevention, 2020). 
Per the CDC (2020), black mothers are three to four times more likely to die due 




twice as likely to experience severe maternal morbidity. The causes of these pregnancy-
related deaths vary to some degree, but the contributions of chronic health conditions 
such as hypertension, diabetes, and chronic heart disease have increased in recent years 
(Centers for Disease Control and Prevention, 2020). It is not by coincidence that the 
conditions which underlie a large number of pregnancy-related deaths are synonymous 
with both the conditions disproportionately affecting black and other minority 
populations, and those which co-occur with PTSD. This variable risk of complications 
based on race and ethnicity is likely precipitated by several factors including access to 
care, quality of care, prevalence of chronic disease, structural racism, and implicit biases 
(Hall, 2015). 
 
Figure 4. Graph of Infant Mortality Rates by Race and Ethnicity. Adapted from Centers 
for Disease Control and Prevention, 2020. 
 
Unlearning Racial Bias  
The National Academy of Medicine (NAM) has reported that racial and ethnic 




income and education are taken into account. The NAM has additionally documented that 
despite the poverty in which people of color disproportionately live, this fact alone cannot 
account for their shortened lifespans when compared to white individuals. Perhaps even 
more disturbing is that black patients are more likely to receive “less desirable 
treatments.” Khiara Bridges (2017), a professor of law and anthropology, offered 
examples such as higher rates of limb amputation and antipsychotic use, despite 
mounting evidence against them, as examples in her discussion of this second-rate 
treatment (Bridges, 2017). 
With these facts in mind, scholars have begun to question the impact of racial 
biases, whether conscious or unconscious, in healthcare. While physicians’ explicit racial 
bias is plausibly not to blame for these disparities, it is also unlikely that these 
inconsistencies in care have emerged as a result of physicians’ intention to cause their 
patients harm. Physicians, despite their extensive medical educations, are not beyond 
exposure to society’s negative racial discourse. Resulting unconscious negative attitudes 
about “othered” racial groups are likely to blame for the inferior care provided to patients 
of color. These individual biases, however, do not operate independently of the systems 
which, too, contribute to the compromised care afforded to these marginalized groups 
(Bridges, 2017). 
Race, as a social construct, reflects the impact of polarized social experiences on 
health outcomes. However, race is often misrepresented in preclinical curricula as a 
biological category based on innate genetic differences. In this way, medical schools may 
potentially play a role in propagating physician bias. Fortunately, the use of race in 




through the use of standardized language, appropriate contextualization, and evidence-
based teachings will allow student physicians to unlearn race-based fallacies instilled by 
society (Amutah, 2021). 
A step toward improving the uses of race and ethnicity in medicine includes 
careful interpretation of disease outcomes without assumption of race- or ethnicity-
specific cause. Abandoning the use of race and ethnicity in medicine entirely is by no 
means a solution to this problem. Doing so would enable inequitable care systems to 
persist via a diversity-blind approach. Instead, the substitution of better disease predictors 
— such as genotypes, genetic ancestry, and biomarkers — could be used to address and 
eliminate inequities in research and medicine (Borrell, 2021). 
Ultimately, the lived experience of racial trauma evokes pathophysiology in the 
body congruent to that of PTSD. The inclusion of racism in the trauma-focused care 
vernacular is imperative to standardize healthcare for people of all races and ethnicities. 
Intervention to mitigate the aforementioned inequities is both an urgent and necessary 
responsibility of all current and aspiring healthcare professionals. To this end, the 
maintenance of such racist tools and practices must be scrutinized and their improvement 
made a priority across all realms of medicine. Advocacy on behalf of the most 
marginalized individuals in our society will effect change to the benefit of those 








RECOMMENDATIONS FOR FUTURE STUDIES 
Downstream disordered functioning following trauma exposure is well-
established and verbosely supported, but discounts the ramifications of racism. A gap 
exists in the literature regarding the long-term effects of PTSD in non-white individuals, 
particularly concerning the role of racism as part of the disease process. Where research 
has been minimally and insufficiently conducted, it has focused primarily on the effects 
of racism in medicine and differential outcomes as they relate to African American 
patients. Because of these research gaps, it is impossible to assert a causal relationship 
exists between acts of race-based discrimination and observable physical and emotional 
symptoms consistent with the racial trauma response. This begs the question, how do 
these same effects impact other minority groups such as Hispanic/Latinx, Asian 
American Pacific Islander, and Native American individuals? Can the concept of 
traumatic discrimination rooted in racial trauma be applied to the discriminatory practices 
impacting individuals who identify as part of the LGBTQIAP+ community? Longitudinal 
studies focused on these minority groups could begin to fill this gap. Particular areas of 
interest include hypervigilance concerning the current political climate, PTSD across the 
lifespan in response to racial trauma, and the chronic stress sequelae related to COVID-
19. 
Progress in this field of study demands that the next edition of the DSM include 
racism as a potential stressor in PTSD. The current definition and criteria required for 
appropriate PTSD diagnosis neglect stressful events associated with the experience of 
racism and racial discrimination. Expansion of the conceptualization of trauma must 




emotional pain (Kirkinis, 2018). Without these evolved diagnostic criteria, affected 
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